By
Download on the App Store

episodes

  • Managing Hyperglycemia in Inpatients: Understanding the Guidelines (Part 1 of 3)
    Curtis Triplitt discusses with Carla Brink, Scientific Project Director for ASHP, recommended target glucose levels in guidelines for inpatient glycemic control. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting.
    Faculty:
    Curtis L. Triplitt, Pharm.D., CDE, Activity Chair
    Associate Director, Diabetes Research Center, Texas Diabetes Institute
    Associate Professor, Department of Medicine, Division of Diabetes
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas
    C.E. Credits: This activity is not eligible for continuing education credits.
    12 min
  • Managing Hyperglycemia in Inpatients: Using Data to Facilitate Changes (Part 2 of 3)
    Kevin Box discusses with Carla Brink, Scientific Project Director for ASHP, what metrics to collect and then how to use them to facilitate improvements in glycemic control for hospitalized patients. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting.
    Faculty:
    Kevin W. Box, Pharm.D.
    Senior Clinical Pharmacist
    UC San Diego Health System
    San Diego, California
    C.E. Credits: This activity is not eligible for continuing education credits.
    18 min
  • Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 3 of 3)
    Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 1 of 3)
    Part 3: Monitoring and Dosing Considerations
    Faculty:
    William E. Dager, Pharm.D., BCPS (AQ-Cardiology)
    Pharmacist Specialist
    UC Davis Medical Center
    Sacramento, California
    Surabhi Palkimas, Pharm.D.
    Pharmacy Clinical Coordinator, Hematology
    University of Virginia Health System
    Charlottesville, Virginia
    C.E. Credits: This activity is not eligible for continuing education credits.
    16 min
  • Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 2 of 3)
    Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 2 of 3)
    Part 2: Considerations in Controlling Bleeding and Preventing Thrombosis
    Faculty:
    William E. Dager, Pharm.D., BCPS (AQ-Cardiology)
    Pharmacist Specialist
    UC Davis Medical Center
    Sacramento, California
    Mark T. Reding, M.D.
    Director, Center for Bleeding and Clotting Disorders
    University of Minnesota Medical Center, Fairview
    Associate Professor
    University of Minnesota Medical School
    Minneapolis, Minnesota
    C.E. Credits: This activity is not eligible for continuing education credits.
    14 min
  • Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 1 of 3)
    Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 1 of 3)
    Part 1: Monitoring and Dosing Considerations
    Faculty:
    William E. Dager, Pharm.D., BCPS (AQ-Cardiology)
    Pharmacist Specialist
    UC Davis Medical Center
    Sacramento, California
    Mark T. Reding, M.D.
    Director, Center for Bleeding and Clotting Disorders
    University of Minnesota Medical Center, Fairview
    Associate Professor
    University of Minnesota Medical School
    Minneapolis, Minnesota
    C.E. Credits: This activity is not eligible for continuing education credits.
    16 min
  • Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 1 of 3)
    Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 1 of 3)
    Part 1: Issues Related to Warfarin Reversal
    Faculty:
    Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator
    Clinical Professor
    The University of Illinois at Chicago College of Pharmacy
    Director, Antithrombosis Center
    The University of Illinois Hospital and Health Sciences System
    Chicago, Illinois
    William E. Dager, Pharm.D., BCPS (AQ-Cardiology)
    Pharmacist Specialist
    UC Davis Medical Center
    Sacramento, California
    James S. Kalus, Pharm.D., BCPS (AQ-Cardiology)
    Senior Manager, Patient Care Services
    Department of Pharmacy Services
    Henry Ford Hospital
    C.E. Credits: This activity is not eligible for continuing education credits.
    15 min
  • Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 2 of 4)
    Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 2 of 4)
    Part 2: Usefulness of Coagulation Assays in Patients taking Target-Specific Oral Anticoagulants
    Faculty:
    Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator
    Clinical Professor
    The University of Illinois at Chicago College of Pharmacy
    Director, Antithrombosis Center
    The University of Illinois Hospital and Health Sciences System
    Chicago, Illinois
    William E. Dager, Pharm.D., BCPS (AQ-Cardiology)
    Pharmacist Specialist
    UC Davis Medical Center
    Sacramento, California
    James S. Kalus, Pharm.D., BCPS (AQ-Cardiology)
    Senior Manager, Patient Care Services
    Department of Pharmacy Services
    Henry Ford Hospital
    C.E. Credits: This activity is not eligible for continuing education credits.
    10 min
  • Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 3 of 4)
    Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 3 of 4)
    Part 3: Balancing Bleeding and Thrombosis Risk
    Faculty:
    Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator
    Clinical Professor
    The University of Illinois at Chicago College of Pharmacy
    Director, Antithrombosis Center
    The University of Illinois Hospital and Health Sciences System
    Chicago, Illinois
    William E. Dager, Pharm.D., BCPS (AQ-Cardiology)
    Pharmacist Specialist
    UC Davis Medical Center
    Sacramento, California
    James S. Kalus, Pharm.D., BCPS (AQ-Cardiology)
    Senior Manager, Patient Care Services
    Department of Pharmacy Services
    Henry Ford Hospital
    C.E. Credits: This activity is not eligible for continuing education credits.
    15 min
  • Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 4 of 4)
    Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 4 of 4)
    Part 4: Reversal of Target-specific Oral Anticoagulants
    Faculty:
    Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator
    Clinical Professor
    The University of Illinois at Chicago College of Pharmacy
    Director, Antithrombosis Center
    The University of Illinois Hospital and Health Sciences System
    Chicago, Illinois
    William E. Dager, Pharm.D., BCPS (AQ-Cardiology)
    Pharmacist Specialist
    UC Davis Medical Center
    Sacramento, California
    James S. Kalus, Pharm.D., BCPS (AQ-Cardiology)
    Senior Manager, Patient Care Services
    Department of Pharmacy Services
    Henry Ford Hospital
    C.E. Credits: This activity is not eligible for continuing education credits.
    10 min